glp 1 restrictions 3 questions to consider: , 1. If other countries treat GLP-1s as risky enough to restrict, why don’t we?, 2. Who benefits from a system with fewer and who carries the risk?, 3. Does Indications for GLP-1/GIP RA Summary
Description
A separate peer-reviewed 2025 study published in Diabetes, Obesity and Metabolism, drawing on data from more than 440,000 adults attending Dubai Academic Health Corporation, found 63% overweight or obese, with 28% classified as obese by BMI criteria
Fekete et al., 2024)
As you might imagine, that would not only be a very painful condition but one that could be life threatening and warrant hospitalization, or even intensive care and it is
Patients using this peptide reported notable improvements in appetite control and body fat reduction when paired with modest dietary and lifestyle changes
